AITINI E

Last name: AITINI E

2013 (v1)

Publication

Metadata-only

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

Clavarezza M Turazza M Aitini E

Background: Neoadjuvant anthracycline- and taxane-based chemotherapy is frequently administered in breast cancer. Pathological complete response (pCR) rates vary according to clinical disease stage and biology of breast cancer. The critical role of angiogenesis in the progression of breast cancer, together with significantly improved efficacy...

Uploaded on: April 14, 2023
2005 (v1)

Publication

Metadata-only

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

Venturini M Del Mastro L Aitini E

Background. To determine whether a dose-dense regimen improves outcome in early breast cancer patients, we compared outcomes with the same fluorouracil, epirubicin, and cyclophosphamide (FEC) chemotherapeutic regimen administered every 3 weeks (FEC21) or administered every 2 weeks (FEC14 including support with filgrastim, a granulocyte...

Uploaded on: April 14, 2023
2012 (v1)

Publication

Metadata-only

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: Experience from the italian observational NEMESI study

Clavarezza M Mustacchi G Gardini A C

No description

Uploaded on: April 14, 2023
2010 (v1)

Publication

Metadata-only

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

Venturini M Bighin C Puglisi F

No description

Uploaded on: April 14, 2023

AITINI E

Recent uploads